Retatrutide cons Still in clinical trials : Retatrutide is not approved yet and is still in trials so its not commercially available for general use
However, there is potential for more serious adverse effects, such as: 1 Vision problems Swelling in the extremities Dizziness or fainting Reduced urination Rash Rapid heart rate Swelling of the throat, tongue, mouth, face, or eyes Problems swallowing or breathing Fever Yellow eyes or skin Chronic upper stomach pain Wegovy, another brand name for semaglutide, may also cause damage to the retina, suicidal ideation, gallstones, pancreatitis, and acute kidney damage
If you're interested in other weight loss injections, Tizaro Tirzepatide may be worth considering
It may help in recovery from injuries, strain, or overuse by facilitating the growth and repair of damaged tissues